This belonged on a health/treatment show, not on a show titled,
Go Rouge & be Rich.
It was all stem cells & the future of the science, nothing about the company or it's future in this up-&-coming tech.
And 3 calls?,...focusing on the possibilites of stem cells & not the company, (I'm sure I heard something along that line).
I'm sure it was decided before hand that the show would focus only on stem cells & the future implications & not on the company.
I'm just wondering why?
It was a great opportunity to tell the world about CBAI, the strides it has taken in this field, the growth in the past 9 months.
If Matt still doesn't want to comment on any pending contracts, he could've side-stepped it.
If I was an investor on the sidelines, I'd like the tech but, DD in a larger, more established company.
Am I wrong that nothing in this interview screamed,
"look at CBAI to invest"?
Perhaps for me, I'll be glad this won't do much in the pps,
not done buying yet.
